Trials / Unknown
UnknownNCT05936125
Short Term Outcomes Of Tricuspid Valve Annuloplasty Using A Flexible Band
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Functional tricuspid regurgitation (FTR) remains a common finding in patients with left-sided valvular heart diseases especially mitral valve regurgitation or stenosis. It is mainly caused by dilatation and flattening of the tricuspid valve (TV) annulus as a result of right ventricular (RV) enlargement and is inevitably affected by the RV function. Multiple studies support the better outcome of using rigid ring annuloplasty over suture repair for treating FTR in concern with the durability and freedom from residual regurgitation. These studies refer the superiority of rigid ring annloplasty to the three-dimensional configuration achieved by such rings which matches the normal tricuspid annulus and, at the same time, to the rigid support of the annulus. On the other hand, other studies support the use of flexible prosthetic bands like Dacron or polytetrafluroethilin (PTFE), especially over suture techniques, due to their easy applicability and availability with good postoperative results. Therefore, suture annyloplasty became nowadays less convenient for FTR repair since both flexible bands and rigid rings appeared to offer good midterm outcomes in recent meta-analysis studies. However, the ideal annuloplasty method for repairing FTR is still debatable between the three-dimensional (3D) rigid rings versus flexible prosthetic bands. In this retrospective comparative study, we share our experience with flexible fashioned bands in FTR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Annuloplasty Using Flexible Band | Tricuspid valve annuloplasty using a flexible band; (Polyethylene terephthalate band): (Dacron band) |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2023-07-07
- Last updated
- 2023-07-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05936125. Inclusion in this directory is not an endorsement.